Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown bluebird bio Inc. BLUE

Alternate Symbol(s):  BLUEV

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.


Top institutional share ownership of bluebird bio Inc

Name Shares Shares % change Value Value % change
State Street Corp 13,151,891 72.7% $63,787 -16.2%
XBI - SPDR(R) S&P(R) Biotech ETF 10,924,275 78.1% $52,983 -13.6%
Wellington Management Group Llp 6,140,000 0.0% $29,779 -51.5%
VGHCX - Vanguard Health Care Fund Investor Shares 6,140,000 0.0% $22,288 -54.0%
Vanguard Group Inc 5,927,556 -18.1% $28,749 -60.2%
BlackRock Inc. 5,837,111 -1.3% $28,309 -52.1%
FBT - First Trust NYSE Arca Biotechnology Index Fund 5,157,063 127.6% $51,519 19.0%
Baker Bros. Advisors Lp 2,499,715 0.0% $12,124 -51.5%
Credit Suisse Ag/ 2,204,763 0.3% $10,693 -51.3%
Goldman Sachs Group Inc 2,093,824 37.7% $10,155 -33.2%

Top institutional buyers of bluebird bio Inc

Name Shares % change Value % change Shares Value
Voloridge Investment Management, Llc 377.5% 131.8% 861,734 $4,179
Federated Hermes, Inc. 252.6% 71.2% 916,803 $4,446
Morgan Stanley 222.9% 56.7% 1,572,805 $7,628
FBT - First Trust NYSE Arca Biotechnology Index Fund 127.6% 19.0% 5,157,063 $51,519
QASCX - Federated MDT Small Cap Core Fund Class A Shares 106.8% -4.9% 1,081,295 $3,925
XBI - SPDR(R) S&P(R) Biotech ETF 78.1% -13.6% 10,924,275 $52,983
Millennium Management Llc 73.7% -15.7% 922,745 $4,475
State Street Corp 72.7% -16.2% 13,151,891 $63,787
Rafferty Asset Management, LLC 66.4% -19.2% 979,122 $4,749
LABU - Direxion Daily S&P Biotech Bull 3X Shares Direxion Daily S&P Biotech Bull 3X Shares 53.8% -29.3% 1,067,937 $3,877

Top institutional sellers of bluebird bio Inc

Name Shares % change Value % change Shares Value
NAESX - Vanguard Small-Cap Index Fund Investor Shares -51.7% -76.6% 846,728 $4,107
Vanguard Group Inc -18.1% -60.2% 5,927,556 $28,749
Jpmorgan Chase & Co -15.9% -59.2% 1,864,533 $9,042
Geode Capital Management, Llc -9.4% -56.0% 1,121,177 $5,437
IWM - iShares Russell 2000 ETF -2.5% -52.7% 1,538,281 $7,461
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares -1.9% -52.4% 1,971,256 $9,561
BlackRock Inc. -1.3% -52.1% 5,837,111 $28,309
VEXMX - Vanguard Extended Market Index Fund Investor Shares -0.2% -51.5% 948,214 $4,599

Information provided by Fintel.io